Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ashley Vo

Showing results (21-30 of 66) with videos related to

Pageof 7
Sort By:
Current Opinion in Organ Transplantation|June 4, 2016
Risk factors associated with the development of histocompatibility leukocyte antigen sensitizationStanley C Jordan, Jua Choi, Irene Kim, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|July 19, 2002
Treatment of parvovirus B-19 (PV B-19) infection allows for successful kidney transplantation without disease recurrenceNoha R Barsoum, Suphamai Bunnapradist, Asha Mougdil, et al.
Transplantation|August 1, 2020
Imlifidase Inhibits HLA Antibody-mediated NK Cell Activation and Antibody-dependent Cell-mediated Cytotoxicity (ADCC) In VitroShili Ge, Maggie Chu, Jua Choi, et al.
Transplantation|December 20, 2002
Posttransplantation lymphoproliferative disorder presenting as a unilateral leg mass 10 years after kidney transplantationSuphamai Bunnapradist, Ashley Vo, Mieko Toyoda, et al.
Transplantation|August 23, 2016
Interleukin-6, A Cytokine Critical to Mediation of Inflammation, Autoimmunity and Allograft Rejection: Therapeutic Implications of IL-6 Receptor BlockadeStanley C Jordan, Jua Choi, Irene Kim, et al.
Clinical Transplantation|March 4, 2014
Histopathologic features of transplant glomerulopathy associated with response to therapy with intravenous immune globulin and rituximabJoseph Kahwaji, Reiad Najjar, Deepika Kancherla, et al.
Transplantation|December 18, 2013
Regulation of anti-HLA antibody-dependent natural killer cell activation by immunosuppressive agentsBong-Ha Shin, Shili Ge, James Mirocha, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|April 18, 2020
Intravenous immunoglobulin significantly reduces exposure of concomitantly administered anti-C5 monoclonal antibody tesidolumabStanley C Jordan, Klaus Kucher, Morten Bagger, et al.
Transplantation|October 1, 2019
Outcomes of Conversion From Calcineurin Inhibitor to Belatacept-based Immunosuppression in HLA-sensitized Kidney Transplant RecipientsSupreet Sethi, Reiad Najjar, Alice Peng, et al.
Transplant Immunology|May 18, 2010
Cellular allo reactivity against paternal HLA antigens in normal multiparous females as detected by intracellular cytokine flow cytometry remains elevated over years despite diminution of anti-HLA antibody levelsMieko Toyoda, Shili Ge, Andy Pao, et al.
Pageof 7

Showing results (21-30 of 66) with videos related to

Sort By:
Pageof 7
Current Opinion in Organ Transplantation|June 4, 2016
Risk factors associated with the development of histocompatibility leukocyte antigen sensitizationStanley C Jordan, Jua Choi, Irene Kim, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|July 19, 2002
Treatment of parvovirus B-19 (PV B-19) infection allows for successful kidney transplantation without disease recurrenceNoha R Barsoum, Suphamai Bunnapradist, Asha Mougdil, et al.
Transplantation|August 1, 2020
Imlifidase Inhibits HLA Antibody-mediated NK Cell Activation and Antibody-dependent Cell-mediated Cytotoxicity (ADCC) In VitroShili Ge, Maggie Chu, Jua Choi, et al.
Transplantation|December 20, 2002
Posttransplantation lymphoproliferative disorder presenting as a unilateral leg mass 10 years after kidney transplantationSuphamai Bunnapradist, Ashley Vo, Mieko Toyoda, et al.
Transplantation|August 23, 2016
Interleukin-6, A Cytokine Critical to Mediation of Inflammation, Autoimmunity and Allograft Rejection: Therapeutic Implications of IL-6 Receptor BlockadeStanley C Jordan, Jua Choi, Irene Kim, et al.
Clinical Transplantation|March 4, 2014
Histopathologic features of transplant glomerulopathy associated with response to therapy with intravenous immune globulin and rituximabJoseph Kahwaji, Reiad Najjar, Deepika Kancherla, et al.
Transplantation|December 18, 2013
Regulation of anti-HLA antibody-dependent natural killer cell activation by immunosuppressive agentsBong-Ha Shin, Shili Ge, James Mirocha, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|April 18, 2020
Intravenous immunoglobulin significantly reduces exposure of concomitantly administered anti-C5 monoclonal antibody tesidolumabStanley C Jordan, Klaus Kucher, Morten Bagger, et al.
Transplantation|October 1, 2019
Outcomes of Conversion From Calcineurin Inhibitor to Belatacept-based Immunosuppression in HLA-sensitized Kidney Transplant RecipientsSupreet Sethi, Reiad Najjar, Alice Peng, et al.
Transplant Immunology|May 18, 2010
Cellular allo reactivity against paternal HLA antigens in normal multiparous females as detected by intracellular cytokine flow cytometry remains elevated over years despite diminution of anti-HLA antibody levelsMieko Toyoda, Shili Ge, Andy Pao, et al.
Pageof 7